Atlas Trials

Safety and Effect of Elbasvir/Grazoprevir Combination Therapy in Hemodialysis Patients With Chronic Hepatitis C

Clinical trial NCT03022006 · UNKNOWN

Trial details

NCT number
NCT03022006
Sponsor
Norte Study Group
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Chronic Hepatitis C
Start date
2017-01-15
Primary completion
2019-03-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.